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CaspasesCaspases (Casp) activity has been associated with the intracellular proteolytic processing of the structural
protein to yield the mature capsid formed by VP70 and with the cell release of human astrovirus (HAstV).
This work describes the role of individual Casp on these events. The activity of initiator (-8, -9) and
executioner (-3/7) Casp was clearly detected at 12 h post-infection. All these proteases were able to cleave
VP90 in an in vitro assay, but this processing was blocked in cells transfected with siRNA against Casp-3, -9,
but not against Casp-8. In contrast, virus release, observed in the absence of cell lysis, was more drastically
affected by either silencing Casp-3 or in the presence of the inhibitor Ac-DEVD-CHO. Cleavage of VP90 to
yield VP70 was mapped at motif TYVD657. These data indicate that the processing of VP90 and the release of
HAstV from the cell are two Casp-related, but apparently independent, events.a del Desarrollo y Fisiología
cional Autónoma de México,
relos, 62250, México. Fax: +52
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Human astroviruses (HAstV) are etiological agents of viral
diarrhea in young children and immunocompromised patients
(Gallimore et al., 2005; Mendez and Arias, 2007). Eight genotypes/
serotypes of HAstV generally present among human population have
been described (Koopmans et al., 1998; Taylor et al., 2001); however,
recent reports revealed the presence of astroviruses (AstV), less
related to the HAstV serotypes previously described, in children; their
clinical relevance is still being investigated (Finkbeiner et al., 2009).
AstV have also been identiﬁed in a variety of animal species, causing
several diseases, besides gastroenteritis (Baxendale and Mebatsion,
2004; Behling-Kelly et al., 2002). Viruses included into the Astro-
viridae family are non-enveloped icosahedral virus of around 40 nm
in diameter, including spikes, and they can be observed as star-like
structures in stool samples (Mendez and Arias, 2007). Their genome is
formed by a single-stranded RNA molecule of plus polarity that
contains three open-reading frames (ORF), named ORF1a, ORF1b, and
ORF2. ORF1a and ORF1b code for proteins that contain motifs of a
serine-protease and the RNA-dependent RNA polymerase, respec-
tively (Jiang et al., 1993). The non-structural proteins nsp1a and
nsp1ab are synthesized from these ORFs and are cleaved by at least
one cellular protease and the viral protease (Geigenmuller et al., 2002;Mendez et al., 2003). On the other hand, ORF2 codes for a protein of
87–90 kDa (named VP90 in HAstV-8) that represents the capsid
precursor polypeptide (Mendez et al., 2002; Monroe et al., 1993;
Willcocks and Carter, 1993). VP90 contains at least three domains
distinguishable by their sequence identity: a highly conserved amino
terminal domain (residues 1 to 415), a highly divergent intermediate
domain (residues 416 to about 647), and the carboxy-end domain,
which is also highly variable (648 to the end) (Jonassen et al., 2001;
Mendez-Toss et al., 2000; Wang et al., 2001). In spite of their low
identity, the last 130 residues of the protein are highly conserved in
the acidic character (Mendez et al., 2004). An intracellular proteolytic
processing of particles containing VP90 to yield particles formed by a
70-kDa protein (VP70), which has been relatedwith thematuration of
HAstV-8 virions, occurs in this region, and the aspartic acid residues
seem necessary for that processing (Mendez et al., 2004). Viral
particles containing VP70 are further on extracellularly cleaved by
trypsin to generate particles with high infectivity, formed by three
proteins of 34, 27, and 25 kDa (named VP34, VP27, and VP25,
respectively) (Mendez et al., 2002). The mechanism by which
infectivity is enhanced due to trypsin treatment is still unknown.
Apoptosis is one type of programmed cell death, involved in many
cellular processes (Doseff, 2004; Hildeman et al., 2007). Particularly, it
has been considered as a cell response to viruses infection in order to
block their replication (Barber, 2001); however, these pathogens have
evolved mechanisms to avoid or modulate that response to
successfully complete their replication cycle (McLean et al., 2008).
Caspases (Casp) are cystein-proteases speciﬁc for aspartic acid
residues that play a key role in this kind of cell death. These enzymes
can be activated (by proteolysis), by a variety of stimuli, including
Fig. 1. Processing of the HAstV structural protein VP90 coincides in time with the
proteolytic cleavage of PARP, which depends on astrovirus replication. Caco-2 cells
were infected with HAstV at moi of 10, and at different time points (from 0 to 24 hpi),
the extracellular and cell-associated fractions were analyzed for infectious viral
particles and protein content. (A) Particles in the extracellular (empty circles) and in
the cell-associated (ﬁlled circles) fractions were quantiﬁed after trypsin treatment.
Cell-associated (B and D) and extracellular (C) proteins were analyzed byWestern blot,
using anti-HAstV (B and C) and anti-PARP (D) as primary antibodies, as indicated. (E
and F) Caco-2 cells were infected with trypsinized virus untreated (UTV) or treated
with psoralen-UV (PUV) and the viral proteins (E) and PARP (F) were analyzed at
20 hpi. Proteins from infected cells with untreated virus maintained in the presence
TRAIL (TR) and Z-VAD.fmk (Z-VAD) were also analyzed, to conﬁrm caspase-dependent
cleavages. M, mock-infected cells; HAstV, astrovirus infected cells; UT, untreated; and
TR, TRAIL-treated cells. Results shown are representative of three independent
experiments made in duplicates.
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Schulze-Osthoff et al., 1998). At least two different groups of Casp
involved in cell death have been recognized, depending on how they
are activated: initiator (such as Casp-8, -9, and -4, among others) and
executioner (such as Casp-3 and -7, among others). Initiator Casp are
usually self-activated when cells sense the stimulus by forming
protein complexes, whose composition and cell localization depend
on the stimuli (MacFarlane, 2003; Riedl and Salvesen, 2007). Two
classical pathways involved in the activation of initiator Casp are
recognized: (a) the extrinsic pathway that frequently results in the
activation of Casp-8 (or Casp-10) is usually initiated by an extracel-
lular signal that recognizes death receptors on the membrane.
Ligands, such as tumor necrosis factor (TNF) or TNF-related apoptosis
ligand (TRAIL), are examples of extrinsic pathways activators. (b) The
intrinsic pathway is frequently initiated by genotoxic stress caused by
drugs such as staurosporine and results in the activation of Casp-9.
This Casp forms complexes with mitochondrial factors for its self-
activation (Fuentes-Prior and Salvesen, 2004; Wang et al., 2005). xA
third route of Casp activation triggered by stress in the endoplasmic
reticulum (ER) has been recognized (Rao et al., 2001). In this case,
Casp-4 in human (Hitomi et al., 2004a) and Casp-12 in mice cells
(Hitomi et al., 2004b; Nakagawa et al., 2000) are the initiator Casp, and
agents such as thapsigargin or tunicamycin can activate them (Hu
et al., 2004). After initiator Casp are activated by self-cleavage, these
proteases cleave and activate executioner proteases, such as Casp-3, -6,
and -7 (Inoue et al., 2009). Executioner Casp aremostly responsible for
the cleavage of cellular proteinswith structural or enzymatic activities,
taking the cell to dramatic alterations and death (Fischer et al., 2003;
Taylor et al., 2008).
Alterations associated with cell death by apoptosis, including
cleavage of cellular structural proteins and of the pro-Casp-8 (pCasp-8)
at late times post-infection, have been observed in HAstV-infected
Caco-2 cells (Guix et al., 2004a; Mendez et al., 2004). Indirect
observations have related Casp activity with the release of the virus
from the cell (Guix et al., 2004a; Mendez et al., 2004) and with the
processing of VP90 to VP70 (Mendez et al., 2004). Both events are
enhanced by TRAIL and blocked by the pan-Casp inhibitor Z-VAD-fmk
(Mendez et al., 2004). Although Casp-8 was found cleaved 48 h post-
infection (hpi) upon HAstV-4 infection (Guix et al., 2004a), no
individual Casp has been associated with virus release and VP90
cleavage, since at that time of infection these events had already
occurred (Mendez et al., 2004). Cleavage of VP90 seems to be necessary
for virus release, but not for viral particles assembly, since infectious
particles can be rescued from cells kept in presence of Z-VAD-fmk
(Mendez et al., 2007). Thus, the mechanism by which VP90 is cleaved
by Casp and the speciﬁc Casp responsible for that cleavage are
unknown. This work was carried out to understand better the
relationship between the cell response to HAstV infection that results
in individual Casp activation and the effect of each of these proteases on
VP90 cleavage and astrovirus release from the host cell.
Results
Intracellular proteolytic processing of VP90 coincides with the release of
astrovirus and the executioner Casp activity
The intracellular proteolytic processing of HAstV-8 VP90 to
generate VP70, the protein that forms the mature particle, occurs at
its carboxy terminus and has been previously related with the release
of the virus from the cell (Mendez et al., 2004). To ﬁnd out whether
that correlation indeed exists, a time-course analysis along infection
was carried out. Cells were infected and the infectious particles, as
well as the viral proteins present in the supernatant and in the cell
fraction, were analyzed. Quantiﬁcation of viral particles yielded a
typical one-step growth curve, in which the amount of infectious
particles started to increase after 8 h, reaching the highest titer at12 hpi, which was maintained up to 24 h (Fig. 1A). This increase was
in the intracellular as well as in the extracellular particles, although,
only about 10% of the total were found extracellular (Fig. 1A).
Regarding viral proteins, VP90 started to be detected at 8 hpi, and it
was present up to 24 hpi, while its proteolytic product VP70 appeared
in the cell fraction at 12 hpi (Fig. 1B). VP70, but not VP90, was clearly
observed in the extracellular fraction at 16 hpi (Fig. 1C).
The processing of VP90 to VP70 has been associated with the
activity of cellular Casp (Mendez et al., 2004), so that to conﬁrm the
activity of executioner Casp, the cleavage of PARP, considered as
classical substrate of these proteases (Germain et al., 1999; Tewari
et al., 1995), was followed in this experiment. As observed in Fig. 1D,
the 85 kDa Casp-dependent cleavage product of PARP appeared at
12 hpi, in coincidence with the cleavage of VP90. The same product
was observed in TRAIL-treated uninfected cells, used as control for
Casp activation (Strater et al., 2002). The Casp-dependent cleavage of
PARP requires a productive astrovirus infection since its inactivation
with psoralen-UV, treatment that reduces drastically its infectivity,
324 M.R. Banos-Lara, E. Méndez / Virology 401 (2010) 322–332although not by affecting the virion structure (Groene and Shaw,
1992) did not induce it, as observed in Fig. 1E and F.
Thus, executioner Casp indeed seem to be active upon astrovirus
infection and their activity coincides in time with the cleavage of
VP90; however, it was unknown whether initiator Casp were
activated at earlier times of infection.
General Casp activation occurs upon HAstV infection
To determine the activation of speciﬁc Casp, as well as the time at
which that occurs, infected cells were analyzed at different time
points. Casp activity was followed by the cleavage of peptides
preferentially recognized by every protease, coupled to aminoluci-
ferin and p-nitroaniline. Substrates included DEVD-, LETD-, and LEHD-
aminoluciferin, preferential substrates for Casp-3/7 (Garcia-Calvo
et al., 1999), Casp-8 (Thornberry et al., 2000) and Casp-9 (Thornberry
et al., 1997) and LEVD-p-nitroaniline, preferential substrate for Casp-4
(Talanian et al., 1997), respectively. Cell treatment with TRAIL,
staurosporine, and tunicamycin, used as controls (Hitomi et al.,
2004a; Stepczynska et al., 2001; Suliman et al., 2001), showed that
activation of Casp-3/7, -8, -9, and -4, respectively, could be detected
by this assay (Fig. 2, panels A to D). Thus, under control conditions,
Casp's activity was clearly detected at 6 h and it was maintained high
up to 24 h post-treatment. Regarding peptide LEVD-p-NA, substrate
for Casp-4, there was a small but signiﬁcant cleaving increase at 12 h
of tunicamycin treatment, indicating activation of this Casp. On the
other hand, cleavage of these substrates by HAstV-infected cell
extracts was clearly observed at 12 hpi, indicating that Casp-3/7, -8, -
9, and -4 had been activated at that time. Casp activity wasmaintained
up to 24 hpi (Fig. 2A to C), except for the transient activity responsible
for cleaving peptide LEVD (Fig. 2D).
Cleavage of Casp substrates can be promiscuous since more than
one activated Casp could cleave the same motif (McStay et al., 2008);
therefore, disappearance of the pro-form of every Casp (pCasp) was
later studied to conﬁrm their activation. Pro-forms of Casp-3, -7, -8,
and -9 were reduced in cells infected with HAstV, as well as after
TRAIL treatments, indicating that more than a single Casp seemed to
be activated upon HAstV infection (Fig. 2E). On the other hand,Fig. 2. Casp activity in cells infected with HAstV. Caco-2 cells were infected with HAstV (HA
(Stau) or Tunicamycin (Tm). At the indicated time points (hpi), cells were harvested to dete
pro-enzymes and Bid (pCasp and Bid, panel E) by immunoblot. Relative units (RU) were ca
independent experiments made in duplicates. The statistical signiﬁcance indicate *Pb0.01,
amount of every pCasp detected by densitometry, taking alpha-tubulin, and mock-infected ccleavage of pCasp-4 was undetected in HAstV-innfected cells or even
upon tunicamaycin, tapsigargin (not shown), and staurosporine
treatment, which induced all the rest pCasp cleavages, except Casp-9
(Fig. 2E). Bid was also observed proteolytically processed during
infection (Fig. 2E) (see discussion below). These results did not
suggest which Casp could be involved in the processing of VP90,
especially because all of them were active at the same time, when
VP90 starts to be processed.
Several Casp are involved in the processing of VP90 to yield VP70
To investigatewhether the processing of VP90was due to a speciﬁc
Casp, experiments to individually knock-down initiator (Casp-4, -8,
and -9) and executioner (Casp-3) Caspwere carried out. The efﬁciency
and speciﬁcity of silencingwere evaluated by determining the absence
of the corresponding pCasp. In every case, analysis included compar-
ison with cells that were transfected with an irrelevant siRNA,
targeting Luciferase (siRNA-Luc). As shown in Fig. 3, the silencing of
a given Casp was efﬁcient and speciﬁc in the absence of any apoptotic
stimulus, since only the silenced pCasp was reduced to 2–4%. The only
exceptionwas a threefold increase of pCasp-8, anda reduction ofCasp-3
after silencing of Casp-4; however, this did not correlate with
modiﬁcations of Casp-3 activity (Fig. 4E); therefore, these observations
were unclear.
To conﬁrm that pCasp reduction was not due to a cleavage because
their activation, but due to their silencing in HAstV-infected cells, the
activated-forms (Casp*, Fig. 4A and B), or the reduction in the activity
(Casp-4 in Fig. 4C and Casp-3 in Fig 4D), were also evaluated. Silencing
of initiator Casp-8 and -9 was efﬁcient in these cells since both pCasp
and Casp* were drastically reduced after transfection with the
corresponding siRNA (Figs. 3 and 4). Although a small amount of
these pCasp was still observed in mock-treated cells after transfection
with those siRNA, thesewere not present after infection, indicating that
HAstV induced their cleavage, and therefore, a residual protease activity
existed in the knocked-down cells. A small reduction of pCasp-8 and
pCasp-9 was also observed after infection of cells transfected with
the control siRNA-Luc, conﬁrming that astrovirus infection indeed
induces their activation. The same was observed after treatmentstV) at moi of 10, mock-infected (M), or treated with either TRAIL (TR), Staurosporine
rmine the activity of individual Casp (shown in panels A to D), as well as the respective
lculated based on the activity in mock-treated cells. Graphs represent results of three
**Pb0.001 and ***Pb0.0001. Numbers below the blots in panel E represent the relative
ells as the reference. Representative results of ﬁve independent experiments are shown.
Fig. 3. Silencing of individual Casp in siRNA-transfected cells. Caco-2 cells were
transfected with the indicated siRNA 3 days before harvesting to detect the indicated
pro-Casp by immunoblot with speciﬁc antibodies. Every gel was also immunoblotted
with antibodies to alpha-tubulin, whose signal was used as loading control. Numbers
below every well indicate results of the densitometric analysis of the signal obtained by
individual anti-Casp, based on the signal obtained with anti-tubulin. Results are
representative of two to three independent experiments.
325M.R. Banos-Lara, E. Méndez / Virology 401 (2010) 322–332with the pro-apoptotic agents TRAIL and staurosporine, respectively,
although with this at a minor extent (Fig. 4A and B). pCasp-4 was
also efﬁciently reduced after transfection with the speciﬁc siRNA
(siRNA-C4) (Fig. 5C). Although reduction of this pro-enzymewas not
obvious after infection or tunicamycin treatment in siRNA-Luc-
transfected cells, the cleavage of peptide LEVD-p-nitroaniline
increased slightly, indicating that activation of Casp-4 occurred in
both conditions. Cleavage of LEVD-p-nitroaniline was reduced to
basal level after transfection with siRNA-C4, indicating that silencing
with this siRNA was efﬁcient and that this protease was activated in
HAstV-infected cells (Fig. 4C). As shown above, the executioner
pCasp-3 was drastically reduced in control cells transfected with the
homologue siRNA-C3, compared with cells transfected with siRNA-Luc,
and it was no longer detected in TRAIL-treated and HAstV-infected
cells, after silencing (Fig. 4D); its activity was also reduced by silencing
(Fig. 4E, see below).
Although Casp silencing was speciﬁc based on individual pCasp
cleavages (Fig. 3), given that Casp activation occurs in a cascade
manner (Kang et al., 1999), it was still possible that blocking
expression of a single Casp could affect indirectly the activation of
downstream executioner Casp in HAstV-infected cells. To clear this,
Casp-3/7 activity was evaluated in cells transfected with every single
siRNA-C4, siRNA-C8, or siRNA-C9 and then infected with HAstV or
treated with the pro-apoptotic agents, as controls. As observed in
Fig. 4E, the activity of Casp-3/7 was reduced in HAstV-infected cells
that were previously transfected with individual siRNA targeting
Casp-8 or -9, compared with those transfected with the irrelevant
siRNA. This observation suggested that these initiator Casp could
modulate the activity of executioner Casp in cells infected with
astrovirus. Cells transfected with siRNA-C8 and treated with TRAIL
showed a lower activity of Casp-3/7, as expected (Fig. 4E). Surpris-
ingly, knocking-down Casp-9 did not affect the activity of the
executioner Casp3/7 in staurosporine-treated cells. On the other
hand, blocking Casp-4 expression had no effect on Casp-3 activity in
HAstV-infected or tunicamycin-treated cells (Fig. 4E). As expected,
transfection of siRNA-C3 dropped Casp-3 activity, even in mock-
treated cells, conﬁrming a basal Casp-3 activity in Caco-2 cells (Fig. 4E).
These data indicated that initiator Casp-8 and -9, but not Casp-4, couldsomehow modulate the activity of the executioner Casp-3 in HAstV-
infected cells, through a still undetermined pathway.
Given that several Casp were activated and that the carboxy-end of
VP90 that is cleaved includes motifs that could be recognized by more
than one of these proteases (Mendez et al., 2004), it was unclear which
one of them could be actually responsible for that processing. Thus, for a
better understanding of the role of these enzymes on VP90 processing,
this was evaluated in cells that were knocked-down for every single
Casp. As shown in Fig. 5, the proteolytic processing of VP90 to VP70was
reduced (between48% and62%) in cells knocked-down for Casp-3, -4, or
-9, but not in cells knocked-down for Casp-8 (Fig. 5A). Unexpectedly,
Casp-3/Casp-9 co-silencingblockVP90processingat the same level than
individual silencing (Fig 5A), suggesting that additional Casp partici-
pated in that cleavage. Reduction in the processing did not directly
correlate with the level at which proteases expression was blocked
(more than 95%, Fig. 3). This ﬁnding could be due to the small fraction of
protease synthesized and activatedupon silencingwas enough to cleave
VP90 or due to an indirect effect, in which such small amount of active
enzyme was able to cleave and activate the Casp actually responsible.
Alternatively, more than one Casp could be directly involved in the
processing of the structural protein. To distinguish among these
possibilities, VP90 was in vitro translated and treated with puriﬁed
active proteases, independently (Fig. 5B). Every Casp used in this
experiment was active since they were able to cleave their respective
substrates coupled to aminoluciferine and p-NA (not shown) and to
cleave in vitro translated Casp-3 dominant negative mutant (DN-C3); as
expected, Casp-3 cleaved DN-C3 at a minor extent (Fig. 5E). Treatment
of VP90 with puriﬁed Casp-3, -8, and -9 yielded a protein of 70 kDa
(Fig. 5B) similar in size to VP70 produced in HAstV-infected cells
(Fig. 5C); Casp-4 yielded a small amount of the same VP70 product. The
70-kDa proteinwas not observedwhen digestionwas carried out in the
presence of Z-VAD.fmk, indicating that cleavages were Casp-dependent
(Fig. 5D). These results indicate that Casp-3, -9, and -8,whose silencing
did not block the processing in cells (Fig. 5A), can recognize VP90 as
substrate to cleave it, likely at the same site, to yield VP70. Thus,
although VP90 can be substrate of Casp, only some of them could
recognize it and contribute for its cleavage during infection.
To elucidate the cleavage site on VP90 that yield VP70, truncated
VP90 mutants that end at DEVD686, EETD672, EPET654, and TY655kvr
(Fig. 6) were produced and compared with the product obtained by
digestion of VP90 with Casp-3. These sites were selected to produce the
truncatedmutants becausemotifs DEVD686, EETD672, and TYVD657were
predicted as cleaved to yield products of around 70 kDa. As shown in
Fig 6B, proteins VP-DEVD686 and VP- EETD672 were larger than the
product observed after digestion of VP90 with Casp-3. On the other
hand, given that motifs potentially recognized by Casp are not present
upstream TYVD657 and that proteins VP-EPET654 and VP- TY655kvr
migrated similarly to VP70, themotif TYVD657 was themost likely to be
cleaved to yield VP70.
Executioner Casp activity may be involved in the release of astrovirus
through a non-lytic mechanism
Previous observations suggested that the release of astrovirus was
independent of cell death, although directly relatedwith the processing
of VP90 (Mendez et al., 2004). Since in this work a general Casp
activation was observed, it was still possible that cell death would be
involved in that step of the replication cycle. To discriminate this
possibility, the integrity of infected cells membrane was determined by
LDH leakage and by trypan blue staining. Release of LDHwas unaffected
during HAstV infection, compared to mock-infected cells, even when
infection was at high moi and maintained up to 48 hpi (Fig. 7A). This
was also observed in cells transfected with every siRNA (Fig. 7B),
indicating that this procedure did not affect cell membrane. No
differences were found among cells when their viability was quantiﬁed
by trypan blue staining, where less than 1% of cells infected at high moi
Fig. 4. Silencing of individual Casp in HAstV-infected cells and its effect on executioner Casp activity. Caco-2 cells were transfected with the indicated siRNA 3 days before either
HAstV infection at moi of 10, or treatment with the indicated drug. After 20 hpi, cells were harvested for immunoblot with antibodies to Casp-8 (panel A), Casp-9 (panel B), Casp-4
(panel C), and Casp-3 (panel D), including the complete (pCasp) and, for Casp-8 and Casp-9, the active forms (Casp*); anti-alpha-tubulin was used as loading control. For Casp-4
(panel C), the activity, instead of the active form, was measured. Cells were also independently harvested at 20 hpi for Casp-3 activity measurements. Relative units (RU) were
calculated similarly to how it was mentioned in Fig. 2. Abbreviations are the same as in Figs. 2 and 3. Average and standard deviation of three independent experiments, made in
duplicates, are shown. *Pb0.01, **Pb0.001, ***Pb0.0001. Average of three independent experiments assayed in duplicate are shown. ***Pb0.0001.
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disruption is not necessary for the virus to be released; however, it was
unclear whether it was dependent on VP90 proteolytic processing, as
previously suggested (Mendez et al., 2004). To elucidate any relation-
ship between these two events of the replication cycle, virus releasewas
evaluated in cells where VP90 processing was blocked due to Casp
silencing (Fig. 7A). As observed in Fig. 7C, reduction in virus release was
more pronounced after Casp-3 silencing, to less than 60%; knocking-
downCasp-4 andCasp-9had a slight effect, if any;while Casp-8 silencing
had no effect. Contrary to previous suggestions (Mendez et al., 2004),
these data showed no correlation between virus release and VP90
processing, but they did with Casp-3 activity. Thereafter, virus releasewas determined by incubating infected cells with Casp inhibitors,
including Ac-DEVD-CHO, a potent inhibitor for executioner Casp-3/7,
and Ac-LEHD-CHO and Ac-IETD-CHO, which have been considered
inhibitors for Casp-9 and Casp-8, respectively (Fig. 7D). In the presence
of Ac-DEVD-CHO, the release of the virus was blocked at similar levels
than those observed after infection in the presence of the pan-Casp
inhibitor Z-VAD.fmk,while inhibitors for the initiator Casphadno effect.
On the contrary, TRAIL treatment increased the exit of the virus from the
cell, as previously reported (Mendez et al., 2004). Thus, executioner
Casp seems to be the most involved in the release of the virus from the
cell through amechanism that does not involve cell lysis, but other Casp
could participate in VP90 processing.
Fig. 5. VP90 is substrate for initiator and executioner Casp. In panel A, Caco-2 cells were transfected with the indicated individual siRNA or co-silencing Casp-3 and Casp-9 (Casp-3/9)
and infected with HAstV, as described in Fig. 3. Viral proteins were detected by immunoblot with anti-HAstV, and the ratio VP90/VP70 was calculated based on densitometry.
Proteins VP90 (panels B and D) and DN-Casp-3 (panel E) were in vitro translated, in the presence of Express-[35S]-Met labeling mix, and either untreated (UT) or digested with the
indicated active enzyme. The same reaction mixtures that included VP90 were incubated in the presence of Z-VAD.fmk (panel D) to conﬁrm Casp-dependent cleavages. Proteins
(panels B, D, and E) were detected by autoradiography after electrophoresed. Proteins of HAstV-infected cells (HAstV, panel C) untreated (UT) or treated either with TRAIL (TR) or
Z-VAD.fmkwere analyzed by immunoblot with anti-HAstV to compare the proteins obtained by in vitro translation. Viral proteins and the products of Casp-digestion are indicated.
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Features indicative of apoptosis have been observed in Caco-2 cells
infected with two HAstV strains of different serotypes (Guix et al.,
2004a; Mendez et al., 2004). In the case of HAstV-8, Casp activity
correlated with the processing of the ORF2 primary product, VP90, at
its carboxy terminus to generate the protein VP70 that forms the
mature extracellular virion. This processing was blocked by the pan-
Casp inhibitor Z-VAD.fmk (Mendez et al., 2004). Such activity was also
associated with the presence of viral particles in the extracellular
fraction of infected cells (Mendez et al., 2004), although not with the
yield of virus progeny because the pan-Casp inhibitor does not block
particles formation (Mendez et al., 2004, 2007). To explore the role of
individual Casp on VP90 processing and virus release, activation of
speciﬁc Casp, as well as these two events, was determined in cells that
were knocked-down by siRNA molecules. Casp-8, but not Casp-9, was
suggested as the main initiator Casp activated upon astrovirus
infection in previous reports (Guix et al., 2004a); however, in this
work, cleavage of initiator and executioner pCasp, as well as their
activity, was detected and continued up to 24 hpi. This observation
impeded to suggest the pathway by which Casp were initially
activated during HAstV infection. As mentioned above, experiments
with HAstV-4 suggested that Casp-8 activate the extrinsic pathway
(Guix et al., 2004a). Cleavage of Bid observed in this work (Fig. 3)
agrees with this assumption; however, results shown here would
indicate that more than one pathway (and stimuli?) would be
probably involved in triggering Casp activation, since initiator and
executioner Casp activation coincided in time. In addition, executionerCasp-3/7 activity was reduced, although not to basal levels, after
silencing both initiator Casp-8 and Casp-9, independently. In
principle, the cleavage of Bid observed in HAstV-infected cells
(Fig. 3) would suggest Casp-8 as the initiator; however, in Casp-8-
silenced infected cells, although Casp-3 activity was reduced, Casp-
dependent cleavages still occurred, such as VP90 (Fig. 5A) and Bid
cleavages (not shown), indicating the activation of Casp in a Casp-8-
independent manner in HastV-infected cells although it cannot be
discarded that other proteases could mediate Bid cleavage in these
conditions, as reported (Yin, 2006). On the other hand, the Casp-
dependent cleavage of VP90 was still observed upon Casp-3/Casp-9
co-silencing, indicating that a Casp activity was present and could be
triggered in the absence of either Casp-8 or Casp-9, and therefore,
suggesting that more than one pathways may be involved in the
activation of Casp activity during infection. Casp activation seems to be
triggered in a post-virus binding/entry step and probably requires
virus translation and/or replication, since particles inactivated by
psoralen-UV, which seems not to affect the structure of the virus and,
therefore, the early steps of infection, as reported for rotavirus
(Groene and Shaw, 1992), were not able to induce such activation.
Whether nsp1a, as suggested previously (Guix et al., 2004a), or
additional factors, triggers Casp activation remains to be determined.
Limited studies on the cell response to HAstV infection exist, which
could give a clue on the mechanism involved in Casp activation.
Recently, extracellular signal-regulated kinases (ERK-1 and ERK-2)
were found active at early stages of astrovirus infection (Moser and
Schultz-Cherry, 2008). Given that these molecules may participate in
triggering apoptosis by phosphorylating pro-apoptotic factors in some
Fig. 6. Processing of VP90 at motif TYVD657 yields VP70. (A) Partial sequence, in which Casp-recognition motifs are underlined, and scheme of the truncated proteins produced are
shown. Proteins are named based on the sequence and the amino acid residue in which they end, as indicated. Minor letters in TY655kvr indicate residues included in the construct
that are not part of the HAstV-8 structural protein. Numbers above the sequence indicate the amino acid residues, based on HAstV-8 sequence, while the white box, the Asp-rich
region in VP90. (B) Proteins were in vitro translated and analyzed by autoradiography, as in Fig. 5. Proteins VP90 and VP90 treated with CAsp-3 (VP90/C3) were used as reference of
the viral proteins migration (as indicated).
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activation of Casp during HAstV infection; however, this hypothesis
requires further investigation.
The processing of VP90 to yield VP70 is blocked by the pan-Casp
inhibitor Z-VAD.fmk and promoted by TRAIL (Mendez et al., 2004),
suggesting a role of Casp on this cleavage in HAstV-infected cells. In this
work, it was conﬁrmed that indeed Casp-3 and -9, but not Casp-8, were
involved in VP90 processing, since this was partially blocked by
individually knocking-down those proteases. However, these proteases
in its active form, including Casp-8, were able to cleave the protein in an
in vitro assay, indicating their potential to recognizeVP90 as substrate in
infected cells. Casp-4, on the other hand, seems to contribute to VP90
processing in infected cells, since this was slightly reduced upon
silencing; however, its role on this event remains unclear since it barely
cleaved in vitro translatedVP90.Hence, the processing of VP90observed
in infected cells could be carried out in a complex manner, in which
more than one Casp, either directly or indirectly, could participate. An
indirect effect was appreciated in the case of knocking-down Casp-9,
which affected negatively the activity of Casp-3; however, VP90
processing was unaffected by Casp-8 silencing that also reduces Casp-3
activity. Thus, more than one factor seems to be involved in this event,
since silencing of individual Casp, independently, or even Casp-3/9 co-
silencing, both of which participate in that cleavage (Fig. 5), did not
block completely the processing of VP90, but it was mostly blocked in
the presence of the pan-Casp inhibitor Z-VAD.fmk. Additional factors,
such as the cellular localization of VP90 and of the proteases and
interaction of these proteins with cell factors, could contribute to that
processing, as it has been described for other Casp substrates (Ramuz
et al., 2003). Regarding cell localization, VP90 has been found in at least
two different cell compartments, in one of which, when associatedwith
membranes, was protected from proteases digestion, especially at its
carboxy-terminus (Mendez et al., 2007), where the Casp recognition
motifs are located (Mendez et al., 2004, 2007). During infection, VP90 is
cleaved at different sites in the carboxy-end region to yield inter-mediates of 75–82 kDa and the more abundant product of cleavage in
the cell, VP70 (Mendez et al., 2004). In vitro, the Casp-dependent
proteolysis of VP90 seems to occur similarly, independently of the Casp
tested, since the putative carboxy-terminal product of 20 kDa was not
observed (data not shown). The structural protein contains an Asp-rich
region containing Casp recognition motifs that are highly conserved
among all astroviruses (Mendez et al., 2004). In the particular case of
HAstV-8 VP90, several motifs (underlined in Fig. 6) including VEND704,
DEVD686, EETD672, and TYVD657 were predicted to be cleaved (analysis
made by GraBCas software) (Backes et al., 2005). To determine which
one of them could be the cleavage site to yield VP70, truncated mutant
proteinswere produced and analyzed. Although EETD andDEVD are the
most conserved among all astroviruses, motif TYVD657, was mapped in
HAstV-8, since proteins that end at residues 654 and 655 gave the size
than that of VP70. Thus, VEND704, EETD672, andDEVD686may be cleaved
to yield the intermediates of 75–82 kDa observed upon infection
(Mendez et al., 2004). It remains to be determined the role that those
cleavages have on astrovirus biology.
As with VP90 processing, the release of HAstV from the cell is
affected similarly with Z-VAD.fmk and TRAIL (Mendez et al., 2004).
Accordingly, in this work, virus exits from the cell coincided with
generalCasp activity at 12 hpi. However, in contrast to that observed for
VP90 processing, virus releasewas differentially affected after silencing
individual Casp, being most affected after transfection with siRNA
against Casp-3. The role of Casp-3 on virus release was conﬁrmed by
infecting Caco-2 in the presence of peptide inhibitors Ac.DEVD-CHO,
Ac-LEHD-CHO, and Ac-IETD-CHO. Ac.DEVD-CHO, speciﬁc for execu-
tioner Casp3/7, was the only one able to block the release of astrovirus,
at similar extent as the pan-Casp inhibitor Z-VAD.fmk did, suggesting
that executioner Casp-3 (and probably Casp-7) is necessary for that
event of the replication cycle. In contrast, silencing of Casp-9 induces a
slight reductionof virus release (approximately 10%), probably through
an indirect effect on Casp-3 as it has been observed in this work and
reported elsewhere (Slee et al., 1999; Yukioka et al., 2008), despite that
Fig. 7. Executioner Casp favors astrovirus release by a non-lytic mechanism. Cells were infected with HAstV at the indicated moi (1 to 10) and harvested at 24 and 48 hpi
(including DMSO treatment as positive control), and the release of LDH was calculated as percentage of the total (panel A). Caco-2 cells were transfected with the indicated
siRNA and infected with HAstV (panels B and C), as indicated in Fig. 2. Extracellular and intracellular LDH activity (panel B) and infectious particles (panel C) were quantiﬁed at
20 hpi and expressed as percentage of the total LDH, and as the ratio of particles found in extracellular/intracellular fractions, compared to that observed in cells transfected
with the siRNA-Luc, respectively. Virus release was also measured from cells infected with HAstV at moi of 10 and incubated for 20 h with MEM alone (UT-untreated), or MEM
containing TRAIL (TR), Z-VAD.fmk (Z-VAD), or the peptide inhibitors Ac-DEVD-CHO (DEVD), Ac-LEHD-CHO (LEHD) and Ac-IETD-CHO (IETD). M, mock-treated cells; DM, DMSO
treatment; UT, untreated cells. Graphs represent the average of at least three independent experiments made in duplicates. *Pb0.01, **Pb0.001.
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mentioned above, the role of Casp-4 on VP90 processing and virus
release was unclear since the effect after its silencing, and its activation
during infection, although consistent,wasweak. Thus, the processingof
VP90 and the release of the virus seem to be two Casp-related but
independent events, so that viral particles containing VP70, once VP90-
containing particles have been processed by Casp-3, -9, or any other
unidentiﬁedCasp, would be able to exit the cell, but only in thepresence
of Casp-3 activity (or other executioner Casp, like Casp-7). Executioner
Casp are mainly responsible for the biochemical and morphological
changes in apoptosis leading to cell death (Slee et al., 2001); therefore,
the release of the virus could be due to an increase of this death. In fact,
cellular proteins such as lamin A and PARP and defects in the
mitochondrial integrity have been observed upon astrovirus infection
(Mendez et al., 2004). However, based on this work and that of others
(Moser et al., 2007), HAstV infection does not enhancedisruptionof cell
membrane, as judged by LDH release, up to 36–48 hpi, even in cells
infected at high moi. A low percentage of infected cells showed to be
TUNEL-positive cells at 24 hpi (Guix et al., 2004a; Mendez et al., 2004),
time at which VP90 processing and virus release had occurred,
indicating that at this time, most of the cells were viable. Thus, cell
viability seems not to be drastically affected inHAstV-infected cells and
therefore does not seem to be necessary for virus release. Previous
reports indicate that astrovirus release was blocked when HAstV-
infected cells were treated with Z-VAD.fmk after being treated with
TRAIL, conditions in which VP70 was the structural protein moreabundant (Mendez et al., 2004), and that frequently increases death,
either by necrosis or autophagy, inmany cell lines (Vandenabeele et al.,
2006). Thus, HAstV release seems to require both Casp activity and
VP90 cleavage, but not cell lysis.
How can astrovirus be released in the absence of cell lysis but with
active executioner Casp? Cell lysis due to secondary necrosis is
observed at late stages of apoptosis, especially when apoptotic cells
are not phagocytosed (Silva et al., 2008). At early times, the apoptotic
cell is not lysed but its membrane blebs to generate apoptotic bodies,
which are usually phagocytosed by other cells. Secondary necrosis
does not seem necessary either for astrovirus release since cell lysis
was not detected at up to 48 hpi and virus release started at 12 hpi. On
the other hand, apoptotic bodies have been suggested as vehicles for
chicken anemia virus release (Teodoro and Branton, 1997) because
virus particles have been found in these structures. Attempts to detect
these structures in Caco-2 cells infected with HAstV have failed so far
(data not shown); therefore, it remains to be determinedwhether this
kind of cell structure is important for virus release.
It is important to mention that Casp activation does not always
result in cell death and secondary necrosis. The extent at what these
enzymes are activated (Kuranaga and Miura, 2007) and the cell
proteins that interact with them, such as alpha-fetoprotein (AFT) (Li
et al., 2009), can modulate cell death progression. In this work, every
Casp tested was not completely processed to yield the activated form
in infected cells, and therefore, their activity did not increase
dramatically, even with TRAIL and staurosporine treatments,
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quently cell death were low in these cells. Previous reports have
associated executioner Casp activity with intracellular transport of
viral proteins. For example, Casp-3 activity is necessary for the
intracellular transport of inﬂuenza virus protein NP (Wurzer et al.,
2003); in addition, a DEVDase Casp activity, encoded by Spodoptera
frugiperda ascovirus, participates in the release of this virus, favoring
the formation of vesicles that contain viral particles, which are
necessary for virus dispersion (Bideshi et al., 2005). On the other
hand, Casp-3 activation has correlated with the cleavage of proteins
that are necessary for transport among different organelles, such as
giantin and syntaxin-5 (Lowe et al., 2004), and proteins involved in
endocytosis (Austin et al., 2006). Although the speciﬁc role of
executioner Casp on astrovirus release remains to be determined, it
is possible that the executioner Casp could participate in, or interfere
with, the intracellular trafﬁc of viral particles that contain VP70, but
not VP90, in their way to the cell exterior.
Until recently, it was considered that non-enveloped viruses, such
as astroviruses, were released from the cell due to cell membrane
destabilization. This has been demonstrated with virus such as
Coxsackie (van Kuppeveld et al., 1997); however, observations with
poliovirus suggest that naked viruses could exit the cell through a non-
lytic mechanism, probably involving autophagic vesicles (Jackson et al.,
2005). In the case of HAstV, it is unknown whether autophagy is
induced during infection, although double membrane vesicles, a
hallmark of this process (Deretic and Levine, 2009), containing
astrovirus particles have been observed in infected cells (Guix et al.,
2004b). Further experiments are necessary to determine whether
autophagy is induced duringHAstV infection andwhether it plays a role
on virus release.
Data of this work suggest that the release of the virus is carried out
through a non-lytic mechanism that depends, at least, on two related
events: the processing of VP90 at the motif TYVD657 to generate
particles formed by VP70 and the activity of executioner Casp.Materials and methods
Virus and cells
Cells from a human colon adenocarcinoma (Caco-2) obtained from
the American Type Culture Collection (ATCC) were used in this work.
Cells were cultivated for 3–4 days in Dulbecco modiﬁed essential
medium (DMEM) (Sigma Cat. D7777), supplemented with non-
essential amino acids (Gibco Cat. 11140) and 10% fetal bovine serum
(FBS) (Cansera) at 37 °C and 10% CO2. Cells were non-differentiated
under these conditions. Viral stocks of HAstV (strain Yuc8, passages
28–31) were prepared as previously described (Mendez et al., 2002),
using 0.5 as themultiplicity of infection (moi), and activating the virus
with trypsin (200 µg/ml, Gibco Cat. 27250-18) for 1 h at 37 °C, and
adding soybean trypsin inhibitor (200 µg/ml) just before inoculation
to the cells. When virus infectivity would be determined later, the
excess of trypsin inhibitor was removed by washing twice the cell
monolayer with MEM. Virus infectivity was quantiﬁed by immuno-
peroxidase staining, using anti-HAstV as primary antibodies, as
previously described (Mendez et al., 2004). In experiments described
below, virus infection was carried out on a conﬂuent cell monolayer at
moi of 10 with trypsin-activated virus, and harvested 20h post-
infection (hpi), unless otherwise is indicated. Inactivated virus was
obtained by psoralen and UV treatment (20 μg/ml and 15 min with
UV360 nm light) after trypsin treatment, as previously described
(Groene and Shaw, 1992). In general, virus titer diminished 4.5 logs
and protein products after trypsin treatment were the same as those
obtained from the native virus under these conditions; therefore, it
was considered that the structure of the inactivated virus was
unaffected by psoralen treatment. In every experiment, mock-infected cells were treated similarly, including the addition of trypsin
and trypsin inhibitor to the inoculum.
Sera and reagents
Rabbit polyclonal serum to HAstV (Yuc8 strain) has been previously
described (Mendez et al., 2004;Mendez-Toss et al., 2000). Antibodies to
Casp-8 (Cat. sc-6136), Casp-9 (Cat. sc-17784), Casp-4 (Cat. sc-56056),
and anti-BID (Cat. sc-11423) were from Santa Cruz Biotechnology;
antibodies to Casp-3 (Cat. 610322), Casp-7 (Cat. 556541), and to the
cleaved form of Casp-8 (Cat. 556466) were from BD Biosciences
Pharmingen, and antibodies to the cleaved form of Casp-9 were from
Calbiochem (Cat AP1026). Anti-Poly-ADP-ribose polymerase (PARP)
(Cat. 9546) and anti-alpha-tubulin (Cat. 18-0092) were purchased to
Cell Signalling and Zymed, respectively. TRAIL (Cat. SE-721), used at
4 µg/ml in this work; Z-Val-Ala-Asp-ﬂuoromethylketone (Z-VAD-fmk,
Cat. P-416) used at 50 µM, Ac-LEHD-CHO (Cat. P-446) andAc-IETD-CHO
(Cat. P-430) used both at 100µM, and Ac-DEVD-CHO (Cat. P-414) used
at 2 µM, were purchased from BIOMOL. Staurosporine (Cat. S4400) that
was used at 2 µM and psoralen (Cat. P8399) were obtained from Sigma,
while Tunicamycin was from Boehringer Mannheim (Cat. 724556) and
used 100 µg/ml. The active proteases Casp-3 (Cat. 235417), Casp-8 (Cat.
218769), Casp-9 (Cat. 218807), and Casp-4 (Cat. 218720) were
purchased from Calbiochem.
Quantiﬁcation of Casp activity
Activity of Casp-3/7, Casp-8, and Casp-9 was determined by
measuring the cleavage of their preferential substrates DEVD, LETD
and LEHD coupled to aminoluciferin, respectively, using Caspase-Glo
reagents (Promega). Based on the manufacturer recommendations,
mock- or infected-cells were lysed with the corresponding reagent
(either Caspase-Glo-3/7, -8, and -9), and the luminescence was
measured after 30 min in the Monolight 2010 apparatus (Analytical
Luminescence Laboratory). On the other hand, Casp-4 activity was
determined by colorimetry, using its preferential substrate LEVD-p-
nitroaniline (LEVD-pNA), according to the manufacturer instructions
(Biovision Cat. 1110-200). Approximately 106 cells were recovered
and lysed with buffer (50 mM HEPES pH 7.4, 0.1%, Chaps, 1 mM DTT,
0.1 mM EDTA, and 0.1% Triton x-100), incubating 10 min on ice;
centrifuged for 1 min at 10,000×g, and the supernatant was 2-fold
diluted with 2× Casp Reaction (CR) buffer (50 mM HEPES pH 7.4,
100 mM sodium chloride, 0.1% Chaps, 10 mM DTT, 1 mM EDTA, 10%
glycerol) (Stennicke and Salvesen, 1997). Every reaction was carried
out with equivalent protein concentration by adding 5 µl of substrate
LEVD-pNA and incubating 2 h at 37 °C. Optical density was measured
at 405 nm. For these experiments, cells were treated with TRAIL,
staurosporine or tunicamycin, as controls.
In vitro translation of VP90 and cleavage by active Casp
The plasmid that expresses HAstV-8 VP90 has been previously
described (Mendez et al., 2007). This construct was used to obtain VP90
truncated mutants that end at motifs DEVD686, EETD672, EPET654, and
TY655kvr, named VP-DEVD686, VP-EETD672, VP-EPET654, and VP-
TY655kvr, respectively. Protein VP-TY655kvr includes 3 amino acid
residues (KVR) at the carboxy-end, which are not present in the
structural astrovirus protein. Plasmid expressing the dominant nega-
tive mutant of Casp-3 (DN-Casp-3) was kindly provided by D. E.
Bredesen (Buck Institute for Research in Aging, CA). Expression of these
proteins was controlled by the phage T7 RNA polymerase promoter.
Linearized plasmids were mixed with a Master Mix of TNT-T7
(Promega) and 10 µCi of Express-[35S]-Met labeling mix (New England
Nuclear) and incubated 1 h at 30 °C. One fraction of this reaction
mixture was added independently to 3 µl of active forms of Casp-3,
Casp-4, Casp-8, or Casp-9 and diluted up to 25 µl with CR buffer. After
Table 1
Features of siRNA molecules.
Gene Sequence Nucleotide Accession Work Concentration Reference
Casp-8 GAUACUGUC UGAUCAUCAATdT 796-814 NM_033356 64 µM This work
Casp-9 GCUUCGUUUCUGCGAACUAdTdT 351-369 NM_032996 32 µM This work
Casp-3 CACAGCACCUGGUUAUUAUdTdT 690-708 NM_032991 3.2 µM This work




Luciferase GUGCGUUGCUAGUACCAACdTdT 851.871 AB261988.1 1.6, 3.2, 6.4 µM Montero et al. (2008)
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and the protein products were separated by SDS-PAGE and analyzed by
autoradiography.
Immunoblot
Cell monolayer was washed twice with MEM at the indicated time
post-infection and harvested in Laemmli Sample loading buffer,
supplemented with Complete proteases inhibitor cocktail (Roche, Cat.
11697). Proteins were electrophoresed in SDS-Polyacrylamide gels
and transferred to nitrocellulose membranes (Millipore Cat.
HATF00010), which were blocked with 5% non-fat dried milk in
Tris-buffered saline solution plus 0.1% Tween-20 (TBS-T). Primary and
secondary antibodies were diluted in the same buffer and incubated
either 1 h at room temperature (when anti-HAstV, anti-tubulin, and
anti-PARP are used) or overnight at 4 °C (with anti-Casp and anti-Bid).
Membranes were washed, and the proteins were visualized by
chemiluminescence (Luminol reagent, Perkin Elmer Cat. NEL104).
Transfection of Caco-2 cells with siRNA
For every siRNA, the optimal concentration that resulted in the
lowest target protein expression and highest transfection efﬁciency
(in every experiment, higher than 95%) was determined experimen-
tally (Table 1). Caco-2 cells were transfected using the Nucleofector
device and solution T, based on the manufacturer recommendations
(Amaxa Cat. VCA-1002). Cells were infected, or treated as indicated in
the corresponding section, after 3 days of transfection.
Lactate dehydrogenase leakage assays
It was carried out with the in vitro Toxicology Assay kit (Sigma Cat.
TOX-7). Brieﬂy, media from the cell culture was removed and stored
at 4 °C, while the cell monolayer was lysed with the buffer included in
the kit (previously diluted 1:10 with MEM), incubating at 37 °C for
45 min. After lysis of the cell fraction, the supernatant initially
recovered and one-tenth of the cell fraction were independently
mixed with the assay mixture and kept 30 min at room temperature.
LDH activity was determined based on the optical density and
expressed as percentage of the total activity.
Statistics
Statistical analysis for every experiment was determined by a two-
tailed T-test with conﬁdence interval of 99%, using the GraphPad
Prism 4.0 Software (GraphPad Software, Inc.).
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